Literature DB >> 10626245

Structure and function of Fas/Fas ligand.

J R Orlinick1, A K Vaishnaw, K B Elkon.   

Abstract

Fas is a member of the TNF receptor family, that contain 2-6 cysteine-rich domains (CRDs) in their extracellular regions, a single transmembrane domain and variably sized intracytoplasmic domains. Fas belongs to a subgroup of family members that have a "death domain" near the carboxy-terminal region of the molecule. This domain binds to adaptor molecules that transmit a death signal to the cell. Signal transduction is complex and involves caspases, ceramides and stress pathways. Fas ligand is biologically active as a homotrimer. Receptor binding has been localized to the C-terminus and a self-association motif to the N-terminus of the ligand extracellular domain. Expression of ligand in a functionally active form is highly regulated at the transcriptional level as well as by cleavage by metalloproteinases. Since Fas/Fas ligand delete activated cells in the peripheral immune system, defects in this pathway predispose to autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626245     DOI: 10.3109/08830189909088485

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  9 in total

1.  Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung.

Authors:  Y Peng; J Trevejo; J Zhou; M W Marino; R G Crystal; E Falck-Pedersen; K B Elkon
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Anaplastic and atypical meningiomas express high levels of Fas and undergo apoptosis in response to Fas ligation.

Authors:  S Weisberg; E Ashkenazi; Z Israel; M Attia; Y Shoshan; F Umansky; C Brodie
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

3.  Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain.

Authors:  M A Boronat; M J García-Fuster; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

4.  Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.

Authors:  Abdiaziz S Mohamood; Mehmet L Guler; Zuoxiang Xiao; Dongfeng Zheng; Allan Hess; Yi Wang; Hideo Yagita; Jonathan P Schneck; Abdel Rahim A Hamad
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

Review 5.  Analysis of gene profile, steady state proliferation and apoptosis of double-negative T cells in the periphery and gut epithelium provides new insights into the biological functions of the Fas pathway.

Authors:  Abdel Rahim A Hamad
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

6.  Modulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain.

Authors:  M Julia García-Fuster; Marcel Ferrer-Alcón; Antonio Miralles; Jesús A García-Sevilla
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-03       Impact factor: 3.000

7.  Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice.

Authors:  K M Pollard; D L Pearson; P Hultman; T N Deane; U Lindh; D H Kono
Journal:  Environ Health Perspect       Date:  2001-01       Impact factor: 9.031

8.  Impairment of Fas-ligand-caveolin-1 interaction inhibits Fas-ligand translocation to rafts and Fas-ligand-induced cell death.

Authors:  Xenia A Glukhova; Julia A Trizna; Olga V Proussakova; Vladimir Gogvadze; Igor P Beletsky
Journal:  Cell Death Dis       Date:  2018-01-22       Impact factor: 8.469

9.  Antiapoptotic Effects of EGb 761.

Authors:  Norma Serrano-García; José Pedraza-Chaverri; José Juan Mares-Sámano; Marisol Orozco-Ibarra; Arturo Cruz-Salgado; Anabel Jiménez-Anguiano; Julio Sotelo; Cristina Trejo-Solís
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-29       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.